18-07-2024, 11:23 PM
Glenmark Pharmaceuticals Secures USFDA Approval for Topiramate Capsules
Glenmark Pharmaceuticals Ltd has secured final approval from the USFDA for its Topiramate Capsules. This medication is recognized as bioequivalent and therapeutically equivalent to Topamax Capsules from Janssen Pharmaceuticals, which are used for treating epilepsy and preventing migraines.
Glenmark Pharmaceuticals Ltd has secured final approval from the USFDA for its Topiramate Capsules. This medication is recognized as bioequivalent and therapeutically equivalent to Topamax Capsules from Janssen Pharmaceuticals, which are used for treating epilepsy and preventing migraines.